ARTICLE
10 November 2025

OECD Preparing Guidance On In Vitro Testing For Intestinal Fate Of Orally Ingested Nanomaterials

BC
Bergeson & Campbell

Contributor

Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.
The Organisation for Economic Co-operation and Development (OECD) has published a draft guidance document on in vitro testing for intestinal fate of orally ingested nanomaterials.
United States Environment
Lynn L. Bergeson Esq.’s articles from Bergeson & Campbell are most popular:
  • within Environment topic(s)
  • in United States
Bergeson & Campbell are most popular:
  • within Tax, Real Estate and Construction and Energy and Natural Resources topic(s)

The Organisation for Economic Co-operation and Development (OECD) has published a draft guidance document on in vitro testing for intestinal fate of orally ingested nanomaterials. According to OECD, the new guidance document "would establish a conceptual framework and procedures for determining intestinal fate of orally ingested nanomaterials using an integrated in vitro approach simulating the human [gastrointestinal tract] environment." The primary objective of the draft guidance document is to provide drivers to identify the most appropriate two-step approach to investigate fate and internalization of different nanomaterials after ingestion. OECD notes, in particular, that it considered the two steps of the digestion process, i.e., behavior of nanomaterials once exposed to different digestive compartments and their interactions with the intestinal mucosa. OECD invites interested parties to contact their National Coordinators at least a week before November 10, 2025.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More